# Drug Schema

# Name
Drug: Example
Alternative_names:
  - Examplumab

# Tissue targets
Tissues:
  - Kidney
  - Lung

Drug_type: Monoclonal Antibody
Class: PDGF Family
Target_class: RTK
Mechanism_of_action: ERBB1-Inhibition

# Papers
Papers:
  - Rosenburg et al. 2016
  - Camidge et al. 2015

# Pharmocology:
Pharmocology:
  Example drug works by binding to the flux capacitor
  ligand site located within the DOC complex.

# Biomarkers
Biomarkers:
  # Responsive Biomarkers
  - Responsive:

    # Expression
    - Overexpression:
      - Gene: CD274
    - Underexpression:
      - Gene:

    # Mutation
    - Mutation:
      - Gene: ABL1
        - SNPs:
          - T315A
          - F317C/I/L/V
          - Y253H
          - E255K/V
          - F359C/I/V

    # CNV
    # TODO: Is this just an integer between -n and n?
    CNV: +2

    # Biallelic Inactivation

    # Gene Fusion
    # TODO: Encoded as a list for gene standardization, otherwise you'd get ALK, EML4-ALK, ALK-EML4, ALK/EML4, etc.
    Fusion:
      - EML4
      - ALK

  # Resistant Biomarkers
  # TODO: Assumption if mutation has no SNPs is that it requires *any* non-synonymous / STOP / indel mutation
  - Resistant:

    # Expression
    - Overexpression:
      - Gene: EGFR
    - Underexpression:
      - Gene:

    # Mutation
    - Mutation:
      - Gene: KRAS
        - SNPs:
      - Gene: BRAF
        - SNPs:
          - V600E
      - Gene: NRAS
        - SNPs:

Notes: >
  Examplumab is targeted to about 30%
  of patients who suffer from the primary
  disease Examplumab is intended for.
